SGMO   $1.51  0.67% Market Closed

Sangamo Therapeutics Inc
Total Cash 27.79M
totalCashPerShare 0.133
EBITDA -184.99M
Total Debt 29.10M
quickRatio 0.727
currentRatio 1.027
Total Revenue 12.28M
debtToEquity 122.824
Revenue/Share 0.066
ROA -0.58289003
ROE -1.94049
grossProfits
freeCashflow -104.23M
operatingCashflow -173.38M
earningsGrowth
revenueGrowth -0.948
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -94.134834
profitMargins 0.0
enterpriseValue 451.07M
forwardPE -9.217391
floatShares 189.59M
sharesOutstanding 208.22M
sharesShort 18.22M
sharesShortPriorMonth 17.50M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.41%
Short Ratio help_outline 7.21%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 0.114
Price To Book help_outline 18.60
earningsQuarterlyGrowth
netIncomeToCommon -249.68M
trailingEps -1.38%
forwardEps -0.23%
enterpriseToEbitda -2.44
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.03 3Q 2024
institutionsCount 161
lastUpdated Nov. 6, 2024, 7:24 p.m.